Literature DB >> 16477009

NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation.

Giuseppina Amadoro1, Maria Teresa Ciotti, Marco Costanzi, Vincenzo Cestari, Pietro Calissano, Nadia Canu.   

Abstract

The altered function and/or structure of tau protein is postulated to cause cell death in tauopathies and Alzheimer's disease. However, the mechanisms by which tau induces neuronal death remain unclear. Here we show that overexpression of human tau and of some of its N-terminal fragments in primary neuronal cultures leads to an N-methyl-D-aspartate receptor (NMDAR)-mediated and caspase-independent cell death. Death signaling likely originates from stimulation of extrasynaptic NR2B-subunit-containing NMDARs because it is accompanied by dephosphorylation of cAMP-response-element-binding protein (CREB) and it is inhibited by ifenprodil. Interestingly, activation of NMDAR leads to a crucial, sustained, and delayed phosphorylation of extracellular-regulated kinases 1 and 2, whose inhibition largely prevents tau-induced neuronal death. Moreover, NMDAR involvement causes the fatal activation of calpain, which, in turn, degrades tau protein into a 17-kDa peptide and possibly other highly toxic N-terminal peptides. Some of these peptides are hypothesized, on the basis of our in vitro experiments, to initiate a negative loop, ultimately leading to cell death. Thus, inhibition of calpain largely prevents tau degradation and cell death. Our findings unravel a cellular mechanism linking tau toxicity to NMDAR activation and might be relevant to Alzheimer's disease and tauopathies where NMDAR-mediated toxicity is postulated to play a pivotal role.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16477009      PMCID: PMC1413822          DOI: 10.1073/pnas.0511065103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation.

Authors:  Manel G Medina; Maria Dolores Ledesma; Jorge E Domínguez; Miguel Medina; Delia Zafra; Francesc Alameda; Carlos G Dotti; Pilar Navarro
Journal:  EMBO J       Date:  2005-04-21       Impact factor: 11.598

2.  Fragmentation of the Golgi apparatus induced by the overexpression of wild-type and mutant human tau forms in neurons.

Authors:  Dalinda Liazoghli; Sebastien Perreault; Kristina D Micheva; Mylène Desjardins; Nicole Leclerc
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

3.  Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.

Authors:  Cathy Andorfer; Christopher M Acker; Yvonne Kress; Patrick R Hof; Karen Duff; Peter Davies
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

Review 4.  Tau, tangles, and Alzheimer's disease.

Authors:  Lester I Binder; Angela L Guillozet-Bongaarts; Francisco Garcia-Sierra; Robert W Berry
Journal:  Biochim Biophys Acta       Date:  2005-01-03

Review 5.  Tau protein as a differential biomarker of tauopathies.

Authors:  Nicolas Sergeant; André Delacourte; Luc Buée
Journal:  Biochim Biophys Acta       Date:  2005-01-03

6.  Cellular and subcellular localization of the 2B-subunit of the NMDA receptor in the adult rat telencephalon.

Authors:  J P Charton; M Herkert; C M Becker; H Schröder
Journal:  Brain Res       Date:  1999-01-23       Impact factor: 3.252

7.  Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type.

Authors:  M Yamamoto-Sasaki; H Ozawa; T Saito; M Rösler; P Riederer
Journal:  Brain Res       Date:  1999-04-10       Impact factor: 3.252

8.  The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration.

Authors:  So-Young Park; Adriana Ferreira
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

9.  Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis.

Authors:  N Canu; L Dus; C Barbato; M T Ciotti; C Brancolini; A M Rinaldi; M Novak; A Cattaneo; A Bradbury; P Calissano
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

10.  Tau suppression in a neurodegenerative mouse model improves memory function.

Authors:  K Santacruz; J Lewis; T Spires; J Paulson; L Kotilinek; M Ingelsson; A Guimaraes; M DeTure; M Ramsden; E McGowan; C Forster; M Yue; J Orne; C Janus; A Mariash; M Kuskowski; B Hyman; M Hutton; K H Ashe
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

View more
  99 in total

Review 1.  Calpain-1 and Calpain-2: The Yin and Yang of Synaptic Plasticity and Neurodegeneration.

Authors:  Michel Baudry; Xiaoning Bi
Journal:  Trends Neurosci       Date:  2016-02-10       Impact factor: 13.837

Review 2.  Location, location, location: altered transcription factor trafficking in neurodegeneration.

Authors:  Charleen T Chu; Edward D Plowey; Ying Wang; Vivek Patel; Kelly L Jordan-Sciutto
Journal:  J Neuropathol Exp Neurol       Date:  2007-10       Impact factor: 3.685

3.  Ethanol enhances tau accumulation in neuroblastoma cells that inducibly express tau.

Authors:  Tania F Gendron; Sharon McCartney; Ena Causevic; Li-Wen Ko; Shu-Hui Yen
Journal:  Neurosci Lett       Date:  2008-07-24       Impact factor: 3.046

Review 4.  The neuropathology of chronic traumatic encephalopathy.

Authors:  Ann C McKee; Thor D Stein; Patrick T Kiernan; Victor E Alvarez
Journal:  Brain Pathol       Date:  2015-05       Impact factor: 6.508

5.  The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity.

Authors:  Nichole E LaPointe; Gerardo Morfini; Gustavo Pigino; Irina N Gaisina; Alan P Kozikowski; Lester I Binder; Scott T Brady
Journal:  J Neurosci Res       Date:  2009-02       Impact factor: 4.164

6.  Amyloid beta-mediated cell death of cultured hippocampal neurons reveals extensive Tau fragmentation without increased full-length tau phosphorylation.

Authors:  Jack Reifert; DeeAnn Hartung-Cranston; Stuart C Feinstein
Journal:  J Biol Chem       Date:  2011-04-11       Impact factor: 5.157

7.  Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models.

Authors:  Qiu-Lan Ma; Marni E Harris-White; Oliver J Ubeda; Mychica Simmons; Walter Beech; Giselle P Lim; Bruce Teter; Sally A Frautschy; Greg M Cole
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

8.  Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model.

Authors:  Meghan N Le; Wonhee Kim; Sangmook Lee; Ann C McKee; Garth F Hall
Journal:  Am J Neurodegener Dis       Date:  2012-11-25

9.  Effect of Phosphorylation and O-GlcNAcylation on Proline-Rich Domains of Tau.

Authors:  Lata Rani; Jeetain Mittal; Sairam S Mallajosyula
Journal:  J Phys Chem B       Date:  2020-03-02       Impact factor: 2.991

10.  Apoptosis and in vitro Alzheimer disease neuronal models.

Authors:  P Calissano; C Matrone; G Amadoro
Journal:  Commun Integr Biol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.